<?xml version="1.0" encoding="UTF-8"?>
<ref id="R12">
 <label>12</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Xu</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Fei</surname>
    <given-names>Y</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>The role of immunosuppressive agents in the management of severe and refractory immune-related adverse events</article-title>. 
  <source>Asia Pac J Clin Oncol</source>
  <year>2020</year>. 
  <pub-id pub-id-type="doi">10.1111/ajco.13332</pub-id>. [Epub ahead of print: 24 Mar 2020]. 
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/32212243?>
 </mixed-citation>
</ref>
